Sally Schofield

Statistics

Publications

Citations

469

H-Index

Active since

2016

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Vanderbilt University

Cleveland Clinic

Sally Schofield is an author at Alnylam Pharmaceuticals (United States) specializing in molecular biology, rna interference, and small interfering ribonucleic acids (sirnas).

Publications per year

2016–2022

Publications

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates

Jayaprakash K. Nair, Husain Attarwala, Alfica Sehgal et al. · Nucleic Acids Research · 2017 · 270 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +17

From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization

Mark K. Schlegel, Maja M. Janas, Yongfeng Jiang et al. · Nucleic Acids Research · 2022 · 90 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

5′-Morpholino modification of the sense strand of an siRNA makes it a more effective passenger

Pawan Kumar, Rubina Parmar, Christopher R. Brown et al. · Chemical Communications · 2019 · 35 citations

Life Sciences, Genetics, Molecular Biology +7

Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs

Mark K. Schlegel, Shigeo Matsuda, Christopher R. Brown et al. · Nucleic Acids Research · 2021 · 32 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Identification of Filamin-A and -B As Potential Biomarkers for Prostate Cancer

Niven R. Narain, Anne R. Diers, Arleide Lee et al. · Future Science OA · 2016 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 6